In advance of November 10, 2026 GDUFA goal date, three commercial lots of Preservative-Free Ketamine have been successfully ...
NRx Pharmaceuticals Inc. (NASDAQ: NRXP) has initiated commercial manufacturing for its preservative-free ketamine product following guidance from the FDA Office of Generic Drugs, according to a ...
Based on FDA Office of Generic Drugs guidance previously announced, NRx has transmitted an initial GMP manufacturing order to its US-based manufacturer. NRx has completed confirmatory GMP audits of ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results